Atlas Trials

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Clinical trial NCT00005762 · COMPLETED

Trial details

NCT number
NCT00005762
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
HIV Infections
Start date
2001-03-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.